Cello Health plc (CLL.L) (CLL) Share Price, News & Analysis

Company Overview

Cello Health plc, together with its subsidiaries, provides marketing services in the United Kingdom, Rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients. The Cello Signal segment provides market research and direct communications services principally to consumer-facing clients. Cello Health plc was incorporated in 2004 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 453,244 shs
• Market Capitalization: £178.84 million
• P/E Ratio: N/A
• Dividend Yield: 1.34%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Business Services
• Industry: Marketing Services
• Sub-Industry: N/A
• Current Symbol: LON:CLL
• CIK: N/A
• Web: www.cellogroup.com
• Phone: +44-20-78128460
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 14.72
• Current Ratio: 1.15
• Quick Ratio: 1.11

Sales & Book Value

• Annual Sales: £166.77 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 20.13
• Book Value: GBX 77.60 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 111,080,000
• Free Float: N/A
• Market Cap: £178.84 million
• Optionable: Not Optionable
• Beta: N/A